Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1981 1
1984 2
1985 1
1990 1
1995 2
1997 1
1998 2
2002 1
2003 2
2004 3
2005 2
2006 3
2007 4
2009 2
2010 3
2011 1
2012 1
2013 2
2014 3
2015 1
2016 2
2017 1
2018 3
2019 1
2020 1
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Impaired ADP-induced platelet aggregation"
Page 1
Does platelet aggregation have any importance in fetal growth restriction pregnancies?
Misan N, Burchardt B, Korszun P, Kapska K, Kapska J, Kawka-Paciorkowska K, Ropacka-Lesiak M. Misan N, et al. Ginekol Pol. 2022;93(12):968-974. doi: 10.5603/GP.a2022.0006. Epub 2022 Mar 24. Ginekol Pol. 2022. PMID: 35325455 Free article.
OBJECTIVES: The aim of the study was to evaluate platelet (PLT) concentration, mean platelet volume (MPV), PLT aggregation and its velocity in pregnancy complicated with fetal growth restriction (FGR) and to analyze the PLT aggregation according to the …
OBJECTIVES: The aim of the study was to evaluate platelet (PLT) concentration, mean platelet volume (MPV), PLT aggregation …
Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y(12) and Link to Residual Platelet Reactivity.
Brambilla M, Becchetti A, Rovati GE, Cosentino N, Conti M, Canzano P, Giesen PLA, Loffreda A, Bonomi A, Cattaneo M, De Candia E, Podda GM, Trabattoni D, Werba PJ, Campodonico J, Pinna C, Marenzi G, Tremoli E, Camera M. Brambilla M, et al. Arterioscler Thromb Vasc Biol. 2023 Oct;43(10):2042-2057. doi: 10.1161/ATVBAHA.123.319099. Epub 2023 Aug 17. Arterioscler Thromb Vasc Biol. 2023. PMID: 37589138 Free PMC article.
BACKGROUND: ADP-induced platelet activation leads to cell surface expression of several proteins, including TF (tissue factor). ...Finally, colchicine impaired in vitro ADP-induced TF expression but not alpha-granule release, suggesting t …
BACKGROUND: ADP-induced platelet activation leads to cell surface expression of several proteins, including TF (tissue …
Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients.
Trovati M, Mularoni EM, Burzacca S, Ponziani MC, Massucco P, Mattiello L, Piretto V, Cavalot F, Anfossi G. Trovati M, et al. Diabetes. 1995 Nov;44(11):1318-22. doi: 10.2337/diab.44.11.1318. Diabetes. 1995. PMID: 7589830
To investigate the effects of insulin on platelets in obesity and in non-insulin-dependent diabetes mellitus (NIDDM)--classic insulin-resistant states--we determined ADP-induced platelet aggregation and platelet cGMP (guanosine 3',5'-cyclic mono …
To investigate the effects of insulin on platelets in obesity and in non-insulin-dependent diabetes mellitus (NIDDM)--classic insulin-resist …
The evolving knowledge on primary hemostasis in patients with cirrhosis: A comprehensive review.
Zanetto A, Campello E, Senzolo M, Simioni P. Zanetto A, et al. Hepatology. 2024 Feb 1;79(2):460-481. doi: 10.1097/HEP.0000000000000349. Epub 2023 Feb 27. Hepatology. 2024. PMID: 36825598 Review.
A more comprehensive and individualized risk assessment should combine hemostatic impairment, the severity of decompensation and systemic inflammation, and the presence of additional factors that may impair platelet function, such as acute kidney injury and b …
A more comprehensive and individualized risk assessment should combine hemostatic impairment, the severity of decompensation and syst …
The prognostic value of platelet aggregation in patients with sepsis.
Chen T, Yang H, Zhao Z, Wang H, Zhong S. Chen T, et al. Allergol Immunopathol (Madr). 2024 May 1;52(3):17-21. doi: 10.15586/aei.v52i3.1039. eCollection 2024. Allergol Immunopathol (Madr). 2024. PMID: 38721951

CONCLUSIONS: Activation of platelets in sepsis intensifies inflammatory response. Patients with sepsis whose ADP-induced PAR was < 60% displayed significant impairment in platelet aggregation function, and had higher mortality rate. Monitorin

…
CONCLUSIONS: Activation of platelets in sepsis intensifies inflammatory response. Patients with sepsis whose ADP-induced PAR w …
Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia.
Cangemi R, Carnevale R, Nocella C, Calvieri C, Cammisotto V, Novo M, Castellani V, D'Amico A, Zerbinati C, Stefanini L, Violi F; SIXTUS Study Group. Cangemi R, et al. Pharmacol Res. 2018 May;131:66-74. doi: 10.1016/j.phrs.2018.03.014. Epub 2018 Mar 22. Pharmacol Res. 2018. PMID: 29577968
In vitro, glucocorticoids-treated platelets showed a dose-dependent decrease of ADP-induced platelet aggregation, TxB(2) production, cPLA(2) phosphorylation and arachidonic acid release from the platelet membrane. ...Glucocorticoids reduce pl …
In vitro, glucocorticoids-treated platelets showed a dose-dependent decrease of ADP-induced platelet aggregation …
Increased Intraplatelet ADMA Level May Promote Platelet Activation in Diabetes Mellitus.
Gawryś J, Wiśniewski J, Szahidewicz-Krupska E, Gajecki D, Leśniewska J, Majda F, Gawryś K, Fortuna P, Mlynarz P, Doroszko A. Gawryś J, et al. Oxid Med Cell Longev. 2020 Sep 29;2020:6938629. doi: 10.1155/2020/6938629. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33062144 Free PMC article.
The correlation of platelet-ADMA with platelet activation and aggregation as well as with other risk factors was also investigated. ...CONCLUSIONS: Type 2 diabetes is related to higher intraplatelet concentration of asymmetric dimethylarginine (ADMA), which m …
The correlation of platelet-ADMA with platelet activation and aggregation as well as with other risk factors was also i …
Assessment of hemostatic changes after initiation of continuous venovenous hemodialysis.
Wand S, Schneider S, Meybohm P, Zacharowski K, Weber CF. Wand S, et al. Clin Lab. 2015;61(3-4):379-87. doi: 10.7754/clin.lab.2014.140931. Clin Lab. 2015. PMID: 25975006
Platelet aggregation in the ADPtest and TRAPtest remained unchanged during the study period. ...CONCLUSIONS: The results of the present study indicate that CRRT may lead to impaired primary hemostasis as shown by a decrease in ex vivo arachidonic acid-induced …
Platelet aggregation in the ADPtest and TRAPtest remained unchanged during the study period. ...CONCLUSIONS: The results of th …
Antiplatelet resistance in outpatients with monitored adherence.
Walter PN, Tsakiris DA, Romanens M, Arnet I, Hersberger KE. Walter PN, et al. Platelets. 2014;25(7):532-8. doi: 10.3109/09537104.2013.845743. Epub 2013 Oct 31. Platelets. 2014. PMID: 24175592
We aimed at assessing factors to resistance when adherence to the antiplatelet drugs and all other oral solid drugs was controlled for. In a pilot study, we tested arachidonic acid and/or ADP-induced in vitro platelet aggregation of 82 outpatients with …
We aimed at assessing factors to resistance when adherence to the antiplatelet drugs and all other oral solid drugs was controlled for. In a …
Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel.
Mangiacapra F, Pellicano M, Di Serafino L, Bressi E, Peace AJ, Di Gioia G, Morisco C, Bartunek J, Wijns W, Bruyne B, Barbato E. Mangiacapra F, et al. Atherosclerosis. 2018 Nov;278:23-28. doi: 10.1016/j.atherosclerosis.2018.08.044. Epub 2018 Aug 30. Atherosclerosis. 2018. PMID: 30236867 Clinical Trial.
BACKGROUND AND AIMS: Increased platelet reactivity (PR) associated with variable degree of coronary microvascular impairment has been reported in patients on clopidogrel after elective percutaneous coronary intervention (PCI). ...RESULTS: ADP-induced P …
BACKGROUND AND AIMS: Increased platelet reactivity (PR) associated with variable degree of coronary microvascular impairment h …
48 results